Anti-GD2 CAR NKT Cells Are Safe and Produce Antitumor Responses in Patients with Relapsed/Refractory Neuroblastoma

Heczey, A; Courtney, A; Ghatwai, N; Thakkar, S; Rathi, P; Xu, X; Ngai, H; Di Piero, EJ; Grilley, B; Sher, A; Dotti, G; Metelitsa, LS

MOLECULAR THERAPY, 2022; 30 (4): 28